Renaissance Technologies’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,869
| Closed | -$29.1K | – | 3483 |
|
|
2024
Q4 | $29.1K | Sell |
4,869
-3,248
| -40% | -$19.4K | ﹤0.01% | 3455 |
|
|
2024
Q3 | $79.2K | Buy |
+8,117
| New | +$79.2K | ﹤0.01% | 3293 |
|
|
2024
Q2 | – | Sell |
-1,482
| Closed | -$67K | – | 3521 |
|
|
2024
Q1 | $67K | Buy |
+1,482
| New | +$67K | ﹤0.01% | 3437 |
|
|
2023
Q2 | – | Sell |
-5,875
| Closed | -$1.75M | – | 3932 |
|
|
2023
Q1 | $1.75M | Buy |
+5,875
| New | +$1.75M | ﹤0.01% | 2106 |
|
|
2022
Q4 | – | Sell |
-2,219
| Closed | -$420K | – | 4128 |
|
|
2022
Q3 | $420K | Sell |
2,219
-1,256
| -36% | -$238K | ﹤0.01% | 3027 |
|
|
2022
Q2 | $734K | Buy |
3,475
+2,300
| +196% | +$486K | ﹤0.01% | 2908 |
|
|
2022
Q1 | $393K | Buy |
+1,175
| New | +$393K | ﹤0.01% | 3334 |
|
|
2020
Q3 | – | Sell |
-9,725
| Closed | -$8.25M | – | 3389 |
|
|
2020
Q2 | $8.25M | Buy |
9,725
+5,194
| +115% | +$4.41M | 0.01% | 1337 |
|
|
2020
Q1 | $1.62M | Sell |
4,531
-150
| -3% | -$53.6K | ﹤0.01% | 2166 |
|
|
2019
Q4 | $1.09M | Sell |
4,681
-175
| -4% | -$40.9K | ﹤0.01% | 2585 |
|
|
2019
Q3 | $547K | Buy |
4,856
+381
| +9% | +$42.9K | ﹤0.01% | 2836 |
|
|
2019
Q2 | $785K | Buy |
4,475
+1,675
| +60% | +$294K | ﹤0.01% | 2805 |
|
|
2019
Q1 | $443K | Buy |
+2,800
| New | +$443K | ﹤0.01% | 2966 |
|